The Genetic and Clinical Predictors of Treatment Response in Depression (GenPod) project is a pharmacogenetic study based in the UK, where genotypic and outcome data are available for 520 patients, randomized to receive citalopram or reboxetine [ 31].
Generally, we observed a stronger and more consistent effect of "species" as compared to "genotypes" suggesting that a gradient of genetic distances among hosts, ranging from phylogenetic to genotypic, can result in a range of different infection outcomes.
A genotypic resistance result was obtained for 1,276/1,312 (97.3%).
Then data transfer 2 (outcomes and genotypic data) was sent to Syreon.
Then data transfer 2 (outcomes and genotypic data) will be sent to Syreon.
The first transfer will be for eligibility and matching data and the second transfer for outcomes and genotypic data.
Additional knowledge could be useful to understand and correlate the impact of specific genotypic markers with clinical outcomes.
In this study, data from treated HIV-1 patients were modeled to predict virological outcome comparing genotypic drug resistance with the most commonly used interpretation systems.
We applied the effect of missingness and deviations from HWE to an MR example consisting of a sample of 10,000 persons with genotypic, intermediate trait, and outcome information.
In single polymorphism evaluations, the distribution of each outcome per genotypic group was assessed with analysis of variance (ANOVA); this is a model-free approach that does not presume a specific model of genetic effect.
